These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 22106843

  • 1. Efficacy and safety of MAP0004, orally inhaled DHE in treating migraines with and without allodynia.
    Tepper SJ, Kori SH, Borland SW, Wang MH, Hu B, Mathew NT, Silberstein SD.
    Headache; 2012 Jan; 52(1):37-47. PubMed ID: 22106843
    [Abstract] [Full Text] [Related]

  • 2. A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine.
    Aurora SK, Rozen TD, Kori SH, Shrewsbury SB.
    Headache; 2009 Jun; 49(6):826-37. PubMed ID: 19545249
    [Abstract] [Full Text] [Related]

  • 3. MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine.
    Aurora SK, Silberstein SD, Kori SH, Tepper SJ, Borland SW, Wang M, Dodick DW.
    Headache; 2011 Apr; 51(4):507-17. PubMed ID: 21457235
    [Abstract] [Full Text] [Related]

  • 4. Dihydroergotamine for early and late treatment of migraine with cutaneous allodynia: an open-label pilot trial.
    Silberstein SD, Young WB, Hopkins MM, Gebeline-Myers C, Bradley KC.
    Headache; 2007 Jun; 47(6):878-85. PubMed ID: 17578539
    [Abstract] [Full Text] [Related]

  • 5. MAP0004, orally inhaled dihydroergotamine for acute treatment of migraine: efficacy of early and late treatments.
    Tepper SJ, Kori SH, Goadsby PJ, Winner PK, Wang MH, Silberstein SD, Cutrer FM.
    Mayo Clin Proc; 2011 Oct; 86(10):948-55. PubMed ID: 21964172
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of a supratherapeutic dose of investigational orally inhaled dihydroergotamine (MAP0004) on QT interval: a randomized, double-blind, active- and placebo-controlled crossover study in healthy volunteers.
    Kori S, Kellerman DJ, Voloshko P, Haugen G.
    Clin Ther; 2012 Sep; 34(9):1920-8. PubMed ID: 22917853
    [Abstract] [Full Text] [Related]

  • 8. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
    Mathew NT, Finlayson G, Smith TR, Cady RK, Adelman J, Mao L, Wright P, Greenberg SJ, AEGIS Investigator Study Group.
    Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
    [Abstract] [Full Text] [Related]

  • 9. Sumatriptan-naproxen migraine efficacy in allodynic patients: early intervention.
    Landy S, Hoagland R, Hoagland NA.
    Headache; 2012 Jan; 52(1):133-9. PubMed ID: 21883200
    [Abstract] [Full Text] [Related]

  • 10. MAP0004: dihydroergotamine mesylate inhalation aerosol for acute treatment of migraine.
    Silberstein S.
    Expert Opin Pharmacother; 2012 Sep; 13(13):1961-8. PubMed ID: 22860628
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.
    Seeburger JL, Taylor FR, Friedman D, Newman L, Ge Y, Zhang Y, Hustad CM, Lasorda J, Fan X, Hewitt D, Ho T, Connor KM.
    Cephalalgia; 2011 May; 31(7):786-96. PubMed ID: 21078681
    [Abstract] [Full Text] [Related]

  • 13. Clarification of developing and established clinical allodynia and pain-free outcomes.
    Landy SH, McGinnis JE, McDonald SA.
    Headache; 2007 Feb; 47(2):247-52. PubMed ID: 17300364
    [Abstract] [Full Text] [Related]

  • 14. Diclofenac potassium liquid-filled soft gelatin capsules in the management of patients with postbunionectomy pain: a Phase III, multicenter, randomized, double-blind, placebo-controlled study conducted over 5 days.
    Riff DS, Duckor S, Gottlieb I, Diamond E, Soulier S, Raymond G, Boesing SE.
    Clin Ther; 2009 Oct; 31(10):2072-85. PubMed ID: 19922878
    [Abstract] [Full Text] [Related]

  • 15. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
    Mathew NT, Landy S, Stark S, Tietjen GE, Derosier FJ, White J, Lener SE, Bukenya D.
    Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
    [Abstract] [Full Text] [Related]

  • 16. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD, Dahlöf CG, Brandes JL, Agosti R, Jones MW, Barrett PS.
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.